1. Lantos PL, Vandenberg SR, Kleihues P . Tumors of the central nervous system. In: Graham DI, Lantos PL (eds). Greenfield's Neuropathology, 6th edn. Vol. 1. Arnold: London, 1996, pp 727–745.
2. Louis DN, Scheithauer BW, Budka H, et al. Meningiomas. In: Kleihues P, Cavenee WK (eds). Pathology and Genetics, Tumors of the Nervous System. World Health Organization Classification of Tumors. IARC Press: Lyon, France, 2000, pp 176–184.
3. Amatya VJ, Takeshima Y, Sugiyama K, et al. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum Pathol 2001;32:970–975.
4. Prives C, Hall PA . The p53 pathway. J Pathol 1999;187:112–126.
5. Momand J, Zambetti GP, Olson DC, et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992;69:1237–1245.